AI Article Synopsis
- Tertiary lymphoid structures (TLS) are linked to better responses to immunotherapy in solid tumors, but their role in enhancing antitumor immunity is often unclear, prompting this study on the interactions between B cells and Trm cells in TLS.
- The study involved examining tumor samples from gastric cancer patients to assess how B cells influence CD103CD8 Trm cells and their ability to combat tumor growth, especially in the context of PD-1 therapy.
- Findings showed that TLS presence and the activation of Trm cells improve anti-PD-1 treatment outcomes, with B cells playing a pivotal role by enhancing Trm cell functions via specific signaling pathways, suggesting new avenues for improving immunotherapy strategies.
Article Abstract
Background & Aims: Although the presence of tertiary lymphoid structures (TLS) correlates with positive responses to immunotherapy in many solid malignancies, the mechanism by which TLS enhances antitumor immunity is not well understood. The present study aimed to investigate the underlying cross talk circuits between B cells and tissue-resident memory T (Trm) cells within the TLS and to understand their role in the context of immunotherapy.
Methods: Immunostaining and H&E staining of TLS and chemokine (C-X-C motif) ligand 13 (CXCL13) cluster of differentiation (CD)103CD8 Trm cells were performed on tumor sections from patients with gastric cancer (GC). The mechanism of communication between B cells and CXCL13CD103CD8 Trm cells was determined in vitro and in vivo. The effect of CXCL13CD103CD8 Trm cells in suppressing tumor growth was evaluated through anti-programmed cell death protein (PD)-1 therapy.
Results: The presence of TLS and CXCL13CD103CD8 Trm cells in tumor tissues favored a superior response to anti-PD-1 therapy in patients with GC. Additionally, our research identified that activated B cells enhanced CXCL13 and granzyme B secretion by CD103CD8 Trm cells. Mechanistically, B cells facilitated the glycolysis of CD103CD8 Trm cells through the lymphotoxin-α/tumor necrosis factor receptor 2 (TNFR2) axis, and the mechanistic target of rapamycin signaling pathway played a critical role in CD103CD8 Trm cells glycolysis during this process. Moreover, the presence of TLS and CXCL13CD103CD8 Trm cells correlated with potent responsiveness to anti-PD-1 therapy in a TNFR2-dependent manner.
Conclusions: This study further reveals a crucial role for cellular communication between TLS-associated B cell and CXCL13CD103CD8 Trm cells in antitumor immunity, providing valuable insights into the potential use of the lymphotoxin-α/TNFR2 axis within CXCL13CD103CD8 Trm cells for advancing immunotherapy strategies in GC.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1053/j.gastro.2023.10.022 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!